EUVIMEDEUVIMED entdecken
Crossref

Targeting TXNIP With Saroglitazar Mitigates Acute Hepatic Injury in Rats Challenged With Thioacetamide: A Multistep Computational and Experimental Approach

Fatma Elnaghy iD, Sameh Saber iD, Eman M Abd El-Kader, Mohammad A Elmorsy, George S G Shehatou

Archiv der Pharmazie · 2025

DOI: 10.1002/ardp.70179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Fatma Elnaghy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt. Hauptthemen laut MEDLINE: Thioacetamide, Chemical and Drug Induced Liver Injury, Chronic, Anti-Inflammatory Agents. Die Arbeit nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute hepatic injury (AHI) is a sudden onset of hepatic inflammation, a key contributor to the progression of diabetes and other disorders. Diabetes mellitus also increases the risk of liver illnesses associated with inflammatory disorders. According to recent studies, Saroglitazar (SAR), originally developed for the treatment of hyperglycemia and dyslipidemia, has also demonstrated notable anti‐inflammatory properties. In our search for a prime therapeutic approach for inflammatory liver disorders in diabetic patients, we investigated the effects of SAR on thioacetamide (TAA)‐induced AHI in rats. In order to investigate possible interactions between SAR and thioredoxin‐interacting protein (TXNIP), this research utilized a multistep methodology that included prediction of computational targets, network analysis, molecular docking, and experimental verification. Findings revealed the anti‐inflammatory potential of SAR, presumably ascribed to its inhibition of the NLRP3 signaling pathway by inhibiting TXNIP, an NLRP3 inflammasome upstream regulator. Furthermore, SAR inhibited the priming signal brought on by NFκB stimulation and the succeeding inflammasome components, cleaved caspase‐1, GSDMD, IL‐1β, and IL‐18. As a result, SAR demonstrated anti‐pyroptotic properties in the injured liver. Moreover, SAR exhibited potential antiapoptotic effects, as indicated by decreased Bax levels, decreased tissue expression of cleaved caspase‐3, and increased BCL2 levels. Improvements in liver function, oxidative stress markers, liver histology, and the liver weight‐to‐body weight ratio all supported these findings. In conclusion, SAR demonstrates potential as a preventive treatment for inflammatory liver disorders. To render these preclinical findings into efficient techniques for enhancing hepatic function, more research is required, particularly in the context of diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThioacetamideChemical and Drug Induced Liver Injury, ChronicAnti-Inflammatory AgentsAnimalsRatsPhenylpropionatesStructure-Activity RelationshipNLR Family, Pyrin Domain-Containing 3 ProteinDose-Response Relationship, DrugSignal TransductionDisease Models, AnimalPyrrolesCell Cycle Proteins

Stichwörter der Autor:innen

NFκBNLRP3 inflammasomeTXNIPacute hepatic injurypyroptosissaroglitazar

Substanzen

ThioacetamideTXNIP protein, ratPhenylpropionatesNLR Family, Pyrin Domain-Containing 3 ProteinAnti-Inflammatory AgentssaroglitazarPyrrolesCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Pharmacology and Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura National University, Gamasa, Egypt.
  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.

ORCID-Profile: Fatma Elnaghy, Sameh Saber

Zitieren

APA

Elnaghy, F., Saber, S., Abd El-Kader, E. M., Elmorsy, M. A., & Shehatou, G. S. G. (2025). Targeting TXNIP With Saroglitazar Mitigates Acute Hepatic Injury in Rats Challenged With Thioacetamide: A Multistep Computational and Experimental Approach. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70179

Vancouver

Elnaghy F, Saber S, Abd El-Kader EM, Elmorsy MA, Shehatou GSG. Targeting TXNIP With Saroglitazar Mitigates Acute Hepatic Injury in Rats Challenged With Thioacetamide: A Multistep Computational and Experimental Approach. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70179

BibTeX
@article{Elnaghy2025,
  author = {Elnaghy, Fatma and Saber, Sameh and Abd El-Kader, Eman M and Elmorsy, Mohammad A and Shehatou, George S G},
  title = {Targeting TXNIP With Saroglitazar Mitigates Acute Hepatic Injury in Rats Challenged With Thioacetamide: A Multistep Computational and Experimental Approach},
  journal = {Archiv der Pharmazie},
  year = {2025},
  doi = {10.1002/ardp.70179}
}
Kostenlos starten →